3min chapter

Diabetes Core Update cover image

Diabetes Core Update – March 2023

Diabetes Core Update

CHAPTER

Simaglotide and Cardiometabolic Risk

Greater weight loss was associated with greater improvements to cardiometabolic risk factors, particularly as you went from 5% weight loss to 20%. They also found very interestingly that some of the improvements appear to be independent of the weight loss. And I think that gives some credence to the previous studies that looked at GOP1 receptor agonist and the improvement in cardiovascular outcome in individuals with diabetes. It seems to be an independent pleurotrauffic effect.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode